ANDA 202493, held by Rk Pharma. Chlorothiazide Sodium.
As of Nov 15, 2026, ANDA 202493 (Chlorothiazide Sodium), held by Rk Pharma, was first approved by FDA on Jun 18, 2014, with 0 approved supplements and 0 published complete response letters.
| Date | Submission | Status | Documents |
|---|---|---|---|
| Jun 18, 2014 | Original application | Approved | None posted |
| Product | Active ingredient | Marketing |
|---|---|---|
| Chlorothiazide SodiumEQ 500MG BASE/VIAL ยท injectable;injection | Chlorothiazide Sodium | Discontinued |
Approvals, supplements, products and documents come from FDA's Drugs@FDA data files, refreshed daily; Drugs@FDA lists approved applications only. Complete response letters are FDA's published letters. Drugs@FDA and FDA complete response letters
